|Last Price$165.96||Day Change (%)-0.09%|
|Open Price$166.36||Day Change ($)-0.15|
|Day Range165.24–166.65||52-Week Range125.37–171.57|
As of Fri 12/26/2014 04:34 PM EST | USD
Perrigo Announces FDA Approval And Launch Of The Generic Version Of Pennsaid® 1.5% w/w
The continuing U.S. stock market rally has diminished the number and similarity of purchases across these top managers.
Recent deals have been driven more by tax strategies than therapeutic synergies.
Favorable conditions are in place for merger-arbitrage ETFs, including increasing M&A activity and the likelihood of higher interest rates.